Experts warn federal spending cuts will make the country sicker and poorer as healthcare costs rise without new treatments.

Bajaj Healthcare’s stock has surged, fuelled by regulatory approvals and expansion into high-growth markets. But with a ...

In 2023, global cannabis sales were estimated at $32 billion, with North America dominating over 75% of total revenue due to widespread legalization in the U.S. and Canada. However, international ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

Charles Schwab Investment Management Inc. boosted its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report ...

In addition to Probudur, the company is also working on Envelta for acute and chronic pain management and NobrXiol for rare pediatric epilepsy. Virpax has established cooperative research and ...

With a current ratio of 29.6x and an Altman Z-Score of 9.66, InvestingPro data indicates strong financial stability despite ongoing R&D investments. Analysts maintain optimistic price targets ...

The state’s $2 billion venture capital play Breakthrough Victoria is under mounting pressure to convince the Allan government ...

The data from these posters was originally presented at the American Epilepsy Society (AES) Annual Meeting in December 2024. The presentations will highlight the company’s ongoing research and ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Tech stocks continued their lightning-quick selloff on Tuesday, with the Nasdaq closing 4% lower to enter correction territory as ...